WISAP Cervix Coagulator, Руководство пользователя

Страница: 15 / 44

GA_Portio-Koagulator_E_150914.docx
Page 15 of 44
3 P
RODUCT
D
ESCRIPTION
3.1 INTENDED USE / PURPOSE
The WISAP 6001 coagulator is used in conjunction with the WISAP Therapy probes
(REF 6002-6009) exclusively for the treatment of benign erythroplakia, cervical
endometriosis, ovula nabothii, chronical cervicitis and haemostasis after knife
conisation.
A distinctive feature is the advantageous and easy handling of the unit:

Coagulation at 60-120 °C

Painless application during the consulting hours in a medical office

Accurate control of intensity

Odorless procedure

Rapid healing without inconvenient vaginal discharge

No contact of patient with electric current

Duration of treatment under 1 minute

No postoperative side structure at the external os uteri

No after-bleeding

Therapy probe head and guiding tube made of stainless steel

Probe head is Teflon-coated, eloxated metal handle with precision plug connection
for instrument cable
3.2 INDICATION/CONTRAINDICATION
The application of the Cervix coagulator and its accessories is not indicated:

in all cases if there is no benign erythroplakia existing.

if there is an endocervical therapy is contraindicated.

for a suspected result/malign tissue.
There are no product-relevant unwanted side effect known.
3.3 USER GROUP
The device may only be operated by surgeons with experience in endoscopic
procedures during minimal invasive surgery and gynecology.
DANGER!
The use of this device is restricted to authorized personnel / physicians
only.